Nuveen New York Select Tax-Free Income Portfolio
NXN · NYSE
2/28/2025 | 8/31/2024 | 2/29/2024 | 8/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -0.4% | 35.8% | -5.9% | – |
| Cost of Goods Sold | -$0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 61.9% | 92.5% | 90.7% | -237.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | -$0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Income | $0 | $0 | $0 | -$0 |
| % Margin | 54.3% | 91.3% | 267.5% | -761.7% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | $0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 54.5% | 91.1% | 267.3% | 97.6% |
| EPS | 0.076 | 0.25 | 0.55 | 0.21 |
| % Growth | -69.8% | -54.5% | 161.9% | – |
| EPS Diluted | 0.076 | 0.25 | 0.55 | 0.21 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 54.3% | 91.3% | 267.5% | 97.6% |